To examine how ALDH1A1 functioned in a breast cancer cell line with high levels of endogenous CCR2, we knocked down ALDH1A1 by stable shRNA expression in parental DCIS.com cells. This evidence concerns the gene ALDH1A1 and ductal breast carcinoma in situ.